Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

242
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
242
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

86
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
86
Criteria for Causality: Bradford Hill Criteria - I01:30

Criteria for Causality: Bradford Hill Criteria - I

235
The Bradford Hill criteria are a group of principles that provide a framework to determine a causal relationship between a specific factor and a disease. There are nine criteria that are pivotal in assessing causality in epidemiological studies. Here's a closer look at Strength, Consistency, Specificity, and Temporality criteria with definitions and examples:
235
Causality in Epidemiology01:21

Causality in Epidemiology

347
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
347
Two-Way ANOVA01:17

Two-Way ANOVA

2.6K
The two-way ANOVA is an extension of the one-way ANOVA. It is a statistical test performed on three or more samples categorized by two factors - a row factor and a column factor. Ronald Fischer mentioned it in 1925 in his book 'Statistical Methods for Researchers.'
The two-way ANOVA analysis initially begins by stating the null hypothesis that there is an interaction effect between the two factors of a dataset. This effect can be visualized using line segments formed by joining the...
2.6K
Statistical Significance01:50

Statistical Significance

20.1K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
20.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sema4A Protects Against Muscle Atrophy and Promotes Repair by Regulating Intracellular Metabolic Signalling.

Journal of cachexia, sarcopenia and muscle·2026
Same author

The role of artificial intelligence in advancing population-based cancer registration.

Science bulletin·2026
Same author

Predicting health-related quality of life for patients with gastroesophageal cancer.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Organizing contemporary oncology care together - A scoping review on multi-hospital oncology networks.

Journal of cancer policy·2025
Same author

Predicting individual hemoglobin abnormalities using longitudinal data in clinical practice.

BMC medical informatics and decision making·2025
Same author

Automating Performance Status Annotation in Oncology Using Llama-3.

Studies in health technology and informatics·2025
Same journal

Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Comparative Effectiveness of Oral Fluoropyrimidines Versus FOLFOX as Adjuvant Therapy for Stage III Colon Cancer: A Retrospective Cohort Study Using Overlap-Weighted Restricted Mean Survival Time Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Association Between EGFR-TKI-Associated Skin Rash and Recorded Mortality in Non-Small Cell Lung Cancer: A Real-World Analysis Accounting for Immortal Time Bias.

Pharmacoepidemiology and drug safety·2026
Same journal

Nationwide Trends in Opioid Consumption in Costa Rica, 2017-2024: Implications for Regulatory Policy and Public Health.

Pharmacoepidemiology and drug safety·2026
查看所有相关文章

相关实验视频

Updated: Jun 13, 2025

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

3.9K

验证因果效应估计的两步框架

Lingjie Shen1, Erik Visser2, Felice van Erning3,4

  • 1Department of Methodology and Statistics, Tilburg University, Tilburg, The Netherlands.

Pharmacoepidemiology and drug safety
|September 10, 2024
PubMed
概括
此摘要是机器生成的。

本研究引入了一个框架,通过调整治疗分配和采样机制,从观察数据中验证因果效应估计. 这种方法允许观察性研究产生与随机对照试验 (RCT) 相似的结果.

关键词:
因果估计的原因估计.采样机制 采样机制治疗分配机制 治疗分配机制验证验证的时间

更多相关视频

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.3K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

6.9K

相关实验视频

Last Updated: Jun 13, 2025

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

3.9K
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.3K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

6.9K

科学领域:

  • 流行病学 流行病学
  • 生物统计学 生物统计学
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 将观察数据与随机对照试验 (RCT) 的因果效应进行比较对于有效性评估至关重要.
  • 在观察性研究中,不同的数据生成机制和未知的治疗分配带来了挑战.
  • 混和抽样偏见可能会损害从观测数据的因果推断.

研究的目的:

  • 提出一种新的两步框架,用于验证基于观测数据的因果效应估计.
  • 为了调整未知的治疗分配机制和不同的采样机制.
  • 提高因果推理在现实世界健康研究中的可靠性.

主要方法:

  • 开发了一种对因果效应的估计器,以计算治疗分配和采样机制.
  • 构建了一个两步框架,用于比较因果效应估计.
  • 在一个名为 RCTrep 的 R 包中实现了框架,以便在实践中应用.

主要成果:

  • 模拟研究表明,拟议的框架从观察数据中产生因果效应估计,与RCT的估计相似.
  • 一个现实世界的应用成功地使用注册数据验证了辅助化疗治疗效果.
  • 该框架有效地解决了与观察数据和RCT数据比较固有的偏见.

结论:

  • 开发的框架促进了观察和RCT数据之间的因果效应估计的可靠比较.
  • 这种方法有助于评估从观察性研究中得出的因果推理的有效性.
  • 该RCTrep包为研究人员提供了一种实用工具,用于实施这种验证方法.